Comparing treatments for fluid overload in cardiogenic shock
Part of Heart & circulation clinical trials.
This trial tests a treatment to help remove extra fluid from the body when the heart is too weak to pump effectively. It may help people in intensive care who have fluid buildup and are at risk of kidney problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and currently in an intensive care unit (ICU).
- Your heart is not pumping strongly enough to meet your body's needs (a condition called cardiogenic shock).
- You have signs of extra fluid in your body, such as swelling or fluid in your lungs.
- You are not already scheduled for kidney dialysis, and you haven't had dialysis in the past 30 days.
- You do not have very high potassium, very acidic blood, or very high urea levels, and you have not had cardiac arrest outside of the hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether starting kidney replacement therapy faster or at the usual time improves outcomes for people with severe heart failure (cardiogenic shock) who are on a heart-lung machine (ECMO) and develop sudden kidney injury.
This trial tests whether a faster rate of fluid removal during dialysis can help hospitalized patients with end-stage kidney disease who have severe fluid buildup. It aims to reduce fluid congestion and improve outcomes.
This trial studies a treatment that removes extra fluid through a catheter placed in the abdomen (peritoneal ultrafiltration) for people with “cardio-renal syndrome” (heart and kidney problems together). It may help those who stay congested despite high-dose water pills (diuretics) and have certain heart circulation and fluid signs.
This study looks at how to safely remove excess fluid from patients in the ICU who have sudden kidney failure and are on a special blood-filtering machine (CRRT). Researchers want to understand which patients have trouble tolerating fluid removal and how to prevent complications.
This trial studies a medicine strategy to remove extra fluid from the body in ICU patients who have fluid overload. It aims to see whether controlled fluid removal is safer and better for recovery than usual care.
This trial compares two types of dialysis (hemodialysis and hemodiafiltration) to see which is better at removing waste from the blood in ICU patients with sudden kidney failure. It may help doctors choose the best treatment for you.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.